Efficacy and tolerability of escitalopram in depressed patients with end stage renal disease: an open placebo-controlled study

Objective: This study aimed to investigate the effectiveness and tolerability of escitalopram in the treatment of major depressive disorder (MDD) in patients with end stage renal disease (ESRD). Method: One hundred and forty-five patients with ESRD were screened with Zung depression scale. The pa...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Aylin Ertekin Yazıcı, Pervin Erdem, Abdullah Erdem, Şenel Tot Acar, Ayşe Devrim Başterzi, Bahar Taşdelen, Kemal Yazıcı
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Mesut Çetin 2021-02-01
Serie:	Psychiatry and Clinical Psychopharmacology
Soggetti:	Escitalopram major depressive disorder end stage renal disease
Accesso online:	https://psychiatry-psychopharmacology.com/index.php/pub/article/view/1941
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!